1. Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia;Zittoun;N. Engl. J. Med.,1995
2. Prognostic factors of patients with acute myeloid leukemia (AML) allografted in first complete remission: an analysis of the EORTC-GIMEMA AML 8A trial;Bone Marrow Transplantation,1996
3. Salvage treatment for primary resistant acute myelogenous leukemia consisting of intermediate dose cytosine-arabinoside and interspaced continous infusions of idarubicin: a phase II study (nr. 06901) of the EORTC Leukemia Cooperative Group;De Witte;Ann. Haematol.,1996
4. Granulocyte-macrophage colony stimulating factor (Molgramostin) associated to induction treatment of acute myelogenous leukemia;Zittoun;J. Clin. Oncol.,1996
5. Quality of life in patients with acute myelogenous leukemia in prolonged first complete remission after bone marrow transplantation (allogeneic or autologous) or chemotherapy: a cross-sectional study of the EORTC-GIMEMA AML 8A study;Zittoun;B.M.T.,1997